Zawya

First Multiple Sclerosis treatment guidelines launched in UAE

The National Multiple Sclerosis Society (NMSS) has launched the first national guidelines for the treatment of Multiple Sclerosis (MS) patients in the UAE. Developed by a dedicated scientific task ...
Yahoo Finance

Simple algorithm helps improve treatment, reduce disparities in MS

MINNEAPOLIS, March 3, 2025 /PRNewswire/ -- A simple treatment algorithm may help reduce treatment disparities for Hispanic and Black people with multiple sclerosis (MS), according to a preliminary ...

Two new subtypes of MS found in ‘exciting’ breakthrough

Exclusive: Scientists uncovered biological strands using artificial intelligence and hope discovery will revolutionise treatment ...
Medscape

European MS Treatment Guidelines Released

PARIS — The first real guidelines on the use of disease-modifying therapies in multiple sclerosis (MS) have been released by a European joint venture between the European Committee for Research and ...
Medscape

Simple Algorithm Reduces Racial Disparities in MS

A simple algorithm to aid in the selection of appropriate disease modifying therapies (DMTs) reduces racial disparities in patients with relapsing multiple sclerosis (MS), early new research showed.
News Medical

Simple algorithm may help reduce treatment disparities in multiple sclerosis

A simple treatment algorithm may help reduce treatment disparities for Hispanic and Black people with multiple sclerosis (MS), according to a preliminary study released today, March 3, 2025, that will ...
Mena FN

Multiple Sclerosis Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis Novartis, Sanofi, Immunic, Biocad, Apimeds, Genentech ...

"Multiple Sclerosis Pipeline Analysis"DelveInsight's,“Multiple sclerosis - Pipeline Insight, 2025” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Multiple ...
The Globe and Mail

Multiple Sclerosis Treatment Market 2034: EMA, PDMA, FDA Approval, Clinical Trials, Epidemiology, Therapies and Companies by DelveInsight

Multiple Sclerosis companies are Immune Response BioPharma, Clene Nanomedicine, Genzyme, ImStem Biotechnology, Rho, Inc., Bristol-Myers Squibb, TG Therapeutics, Inc ...
The Globe and Mail

Multiple Sclerosis Treatment Market 2034: EMA, PDMA, FDA Approval, Clinical Trials, Medication, Epidemiology, Prevalence, Therapies and Companies by DelveInsight

Multiple Sclerosis companies are Immune Response BioPharma, Clene Nanomedicine, Genzyme, ImStem Biotechnology, Bristol-Myers Squibb, TG Therapeutics, Hoffmann-La ...